2. Portfolio Analysis and Strategy Execution
2.1 What are the key challenges and opportunities that correspond in each of P&Gs portfolios?
2.1.2 In Consumer Health- Nesh
Introduction on P&Gs Consumer Health
Procter and Gamble has a 1.3% value share (peak was at 1.7% in 2006) in Consumer Health Segment. P&Gs largest consumer wellness category is over the counter (OTC), in which it derives most sales from cough, cold and allergy remedies and digestive remedies. It also has presence in herbal tea/traditional products, vitamins and dietary supplements (VDS), child-specific consumer health unwritten dispense and feminine hygiene. It has no meaningful presence in cargo management, sports nutrition or allergy care.
P&G suffers from pressure due to competitors launch of prescription to OTC launches, clannish label/cheaper brands and legislative issues in US, which is its key market. While it has upset share in that area, it has been driving up sales for its VDS, herbal/traditional products and child-specific consumer health. It also has been divesting prescription drugs due to lack of maturation and market demand.
Most its R&D and merchandise investments also remain in oral care go ignoring OTC and other categories.
Source: Euromonitor
Health Care last sales change magnitude 5% to $12 billion on 5% growth in unit volume. Volume increased high single(a) digits in developing regions and low single digits in developed regions. Breakdown in the categories as follows:
viva Care grew mid-single digits tooshie initiative activity and incremental selling support of Crest and Oral-B. Global market share of the oral care category was up over half a point.
Personal Health Care grew low single digits behind higher shipments of Vicks in North America and the developing regions, partially...If you hope to get a full essay, order it on our website: Orderessay
If you want to get a full essay, wisit our page: write my essay .
No comments:
Post a Comment